← Companies
Medline Inc.
Data as of Oct 8, 2026
Reported federal lobbying
$4.3M
36 filings · latest Jul 20, 2026
Federal contracts since 2024
$815M
312 awards · latest Sep 20, 2026
Lobbying
$4,280,000 in reported federal lobbying spend across 36 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Health Issues +1$1.3M3 filings
- Trade (domestic/foreign)$1M17 filings
- Veterans +2$460K1 filing
- Tariff (miscellaneous tariff bills) +3$460K1 filing
- Tariff (miscellaneous tariff bills) +2$440K1 filing
- Tariff (miscellaneous tariff bills) +3$230K1 filing
Latest filings, Jul 2026 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Jul 20, 2026 | MEDLINE Health Issues · Trade (domestic/foreign) Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1 | $400,000 |
| Jul 20, 2026 | STEPTOE LLP for MEDLINE INDUSTRIES LP Trade (domestic/foreign) Engagement with USTR, DOC on issues related to Section 232 investigation | $80,000 |
| Jul 20, 2026 | MAYER BROWN LLP for MEDLINE INDUSTRIES L.P. (FORMERLY MEDLINE INDUSTRIES INC.) Unspecified | $0 |
| Jul 19, 2026 | VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC) for MEDLINE Trade (domestic/foreign) Trade policy affecting medical-surgical products and the health care supply chain. | $10,000 |
| Jul 14, 2026 | VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC) for MEDLINE Trade (domestic/foreign) Trade policy affecting medical-surgical products and the health care supply chain. | $0 |
| Jul 10, 2026 | CORNERSTONE GOVERNMENT AFFAIRS, INC. for MEDLINE Trade (domestic/foreign) · Tariff (miscellaneous tariff bills) · Health Issues General issues related to health care and trade policy affecting medical-surgical products and the health care supply chain.
General issues related to health care and trade policy affecting medical-surgical products and the health care su | $80,000 |